Journal of Digestive Cancer Research

Korean Society of Gastrointestinal Cancer Research (대한소화기암연구학회)
권호 표지

Current Research Status of Irreversible Electroporation for Hollow Viscus Organ of Gastrointestinal Tract

위장관 비가역적 전기천공법의 연구 현황

  • Keum, Bora (Division of Gastroenterology and Hepatology, Department of Internal Medicine, Korea University Anam Hospital, Korea University College of Medicine) ;
  • Choi, Hyuk Soon (Division of Gastroenterology and Hepatology, Department of Internal Medicine, Korea University Anam Hospital, Korea University College of Medicine) ;
  • Jeon, Han Jo (Division of Gastroenterology and Hepatology, Department of Internal Medicine, Korea University Anam Hospital, Korea University College of Medicine)
  • 금보라 (고려대학교 의과대학 내과학교실, 고려대학교 안암병원 소화기내과) ;
  • 최혁순 (고려대학교 의과대학 내과학교실, 고려대학교 안암병원 소화기내과) ;
  • 전한조 (고려대학교 의과대학 내과학교실, 고려대학교 안암병원 소화기내과)
  • Received : 2020.06.05
  • Accepted : 2020.06.08
  • Published : 2020.06.30

⟨ Previous Next ⟩

Abstract

Ablative therapy has drawn attention for cancer treatment as minimally invasive therapy. Recently, irreversible electroporation which has a different concept from the existing ablation method has emerged. Although gastrointestinal tract cancer is commonly managed by ablation such as liver, pancreas cancer, hollow viscus cancer is extremely challenging for applying ablative therapy because of its high perforation risk. Therefore, several studies about hollow viscus irreversible electroporation will be introduced in this review regarding its pre-clinical relevance.

Keywords

References

  1. Siegel RL, Miller KD, Goding Sauer A, et al. Colorectal cancer statistics, 2020. CA: A Cancer Journal for Clinicians 2020. https://doi.org/10.3322/caac.21405
  2. Etemadi A, Safiri S, Sepanlou SG, et al. The global, regional, and national burden of stomach cancer in 195 countries, 1990-2017: a systematic analysis for the global burden of disease study 2017. The Lancet Gastroenterology & Hepatology 2020;5(1):42-54. https://doi.org/10.1016/s2468-1253(19)30328-0
  3. Vuik FE, Nieuwenburg SA, Bardou M, et al. Increasing incidence of colorectal cancer in young adults in Europe over the last 25 years. Gut 2019;68(10):1820-1826. https://doi.org/10.1136/gutjnl-2018-317592
  4. Jung K-W, Won Y-J, Kong H-J, Lee ES. Prediction of cancer incidence and mortality in Korea, 2019. Cancer Res Treat 2019;51(2):431-437. https://doi.org/10.4143/crt.2019.139
  5. Mariotto AB, Yabroff KR, Shao Y, Feuer EJ, Brown ML. Projections of the cost of cancer care in the United States: 2010-2020. Journal of the National Cancer Institute 2011;103(2):117-128. https://doi.org/10.1093/jnci/djq495
  6. Peery AF, Crockett SD, Murphy CC, et al. Burden and cost of gastrointestinal, liver, and pancreatic diseases in the United States: update 2018. Gastroenterology 2019;156(1):254-272.e11. https://doi.org/10.1053/j.gastro.2018.08.063
  7. Nam SY, Choi IJ, Park KW, et al. Effect of repeated endoscopic screening on the incidence and treatment of gastric cancer in health screenees. European Journal of Gastroenterology & Hepatology 2009;21(8):855-860. https://doi.org/10.1097/MEG.0b013e328318ed42
  8. Chu KF, Dupuy DE. Thermal ablation of tumours: biological mechanisms and advances in therapy. Nature Reviews Cancer 2014;14(3):199-208. https://doi.org/10.1038/nrc3672
  9. Ahmed M, Brace CL, Lee FT, Goldberg SN. Principles of and advances in percutaneous ablation. Radiology 2011;258(2):351-369. https://doi.org/10.1148/radiol.10081634
  10. Pereira PL. Actual role of radiofrequency ablation of liver metastases. European Radiology 2007;17(8):2062-2070. https://doi.org/10.1007/s00330-007-0587-0
  11. Weaver JC. Electroporation: a general phenomenon for manipulating cells and tissues. Journal of Cellular Biochemistry 1993;51(4):426-435. https://doi.org/10.1002/jcb.2400510407
  12. Jiang C, Davalos RV, Bischof JC. A review of basic to clinical studies of irreversible electroporation therapy. IEEE Transactions on Bio-medical Engineering 2015;62(1):4-20. https://doi.org/10.1109/TBME.2014.2367543
  13. Kotnik T, Frey W, Sack M, Meglic SH, Peterka M, Miklavcic DJTib. Electroporation-based Applications in Biotechnology 2015;33(8):480-488.
  14. Jaroszeski MJ, Gilbert R, Nicolau C, Heller R. In vivo gene delivery by electroporation. Advanced Drug Delivery Reviews 1999;35(1):131-137. https://doi.org/10.1016/S0169-409X(98)00068-4
  15. Okino M, Mohri H. Effects of a high-voltage electrical impulse and an anticancer drug on in vivo growing tumors. Japanese Journal of Cancer Research: Gann. 1987;78(12):1319-1321.
  16. Lee EW, Thai S, Kee ST. Irreversible electroporation: a novel image-guided cancer therapy. Gut and Liver 2010;4 Suppl 1(Suppl 1):S99-S104. https://doi.org/10.5009/gnl.2010.4.S1.S99
  17. Rubinsky B, Onik G, Mikus P. Irreversible electroporation: a new ablation modality--clinical implications. Technology in Cancer Research & Treatment 2007;6(1):37-48. https://doi.org/10.1177/153303460700600106
  18. Narayanan G, Froud T, Suthar R, Barbery K. Irreversible electroporation of hepatic malignancy. Semin Intervent Radiol 2013;30(1):67-73. https://doi.org/10.1055/s-0033-1333655
  19. Martin RCG, 2nd. Use of irreversible electroporation in unresectable pancreatic cancer. Hepatobiliary Surg Nutr 2015;4(3):211-215. https://doi.org/10.3978/j.issn.2304-3881.2015.01.10
  20. Pech M, Janitzky A, Wendler JJ, Strang C, Blaschke S, Dudeck O, et al. Irreversible electroporation of renal cell carcinoma: a first-in-man phase I clinical study. Cardiovascular and Interventional Radiology 2011;34(1):132-138. https://doi.org/10.1007/s00270-010-9964-1
  21. van den Bos W, de Bruin DM, Muller BG, Varkarakis IM, Karagiannis AA, Zondervan PJ, et al. The safety and efficacy of irreversible electroporation for the ablation of prostate cancer: a multicentre prospective human in vivo pilot study protocol. BMJ Open 2014;4(10):e006382. https://doi.org/10.1136/bmjopen-2014-006382
  22. Luo X, Liang X, Li J, Shi J, Zhang W, Chai W, et al. The effects of irreversible electroporation on the colon in a porcine model. PloS One 2016;11(12):e0167275. https://doi.org/10.1371/journal.pone.0167275
  23. Phillips MA, Narayan R, Padath T, Rubinsky B. Irreversible electroporation on the small intestine. British Journal of Cancer 2012;106(3):490-495. https://doi.org/10.1038/bjc.2011.582
  24. Lee JM, Choi HS, Kim ES, Keum B, Seo YS, Jeen YT, et al. Characterization of irreversible electroporation on the stomach: A feasibility study in rats. Scientific Reports 2019;9(1):9094. https://doi.org/10.1038/s41598-019-45659-1
  25. Schoellnast H, Monette S, Ezell PC, Single G, Maybody M, Weiser MR, et al. Irreversible electroporation adjacent to the rectum: evaluation of pathological effects in a pig model. Cardiovascular and Interventional Radiology 2013;36(1):213-220. https://doi.org/10.1007/s00270-012-0393-1